Renal effects of dapagliflozin in patients with type 2 diabetes

by Merlin C. Thomas
Published 2014-06-01

: Type 2 Diabetes and Readmission for Heart Failure

by Merlin C Thomas
Published 2018-06-01

PPAR Agonists and Cardiovascular Disease in Diabetes

by Anna C. Calkin, Merlin C. Thomas
Published 2008-01-01

Dietary intake and hospitalisation due to diabetic ketoacidosis and hypoglycaemia in individuals with type 1 diabetes

by Aila J. Ahola, Valma Harjutsalo, Merlin C. Thomas, Carol Forsblom, Per-Henrik Groop
Published 2021-01-01

A Review of the External Validity of Clinical Trials with Beta-Blockers in Heart Failure

by Pupalan Iyngkaran, Samia R. Toukhsati, Merlin C. Thomas, Michael V. Jelinek, David L. Hare, John D. Horowitz
Published 2016-01-01

A Review of the External Validity of Clinical Trials with Beta-Blockers in Heart Failure

by Pupalan Iyngkaran, Samia R. Toukhsati, Merlin C. Thomas, Michael V. Jelinek, David L. Hare, John D. Horowitz
Published 2016-10-01

Does a nephron deficit exacerbate the renal and cardiovascular effects of obesity?

by Seshini Gurusinghe, Russell D Brown, Xiaochu Cai, Chrishan S Samuel, Sharon D Ricardo, Merlin C Thomas, Michelle M Kett
Published 2013-01-01